CD274 and neoplasm: We have been discovering the factors related to the response as well; some of them were evaluated as predictive biomarkers in clinical studies, such as PD-L1 expression (tumor and immune cells), high tumor mutational burden (TMB), and mismatch repair deficiency or microsatellite instability in the tumor biopsy.